Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Exelixis delivers cancer antibody targets to PDL for further development

July 16, 2001

Neutrophil elastase inhibitor prevents cancer metastasis in animal model

July 16, 2001

Idec submits additional information for Zevalin BLA

July 16, 2001

New Photofrin indication filed with Canadian authorities

July 16, 2001

Tie2 receptor kinase inhibitors useful for angiogenic disorders

July 13, 2001

EntreMed begins enrollment of initial patients in phase I/II study of rhEndostatin

July 13, 2001

Use of PRAC protein in cancer Rx available for licensing from NIH

July 13, 2001

Promising phase III trial results reported with Leuprogel three-month depot

July 11, 2001

Aventis transfers selected product rights to Introgen Therapeutics through investment

July 11, 2001

WHI-P131 useful for preventing colorectal cancer

July 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...